Clincosm LogoSign in Get a demo

Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease

Sponsor
Stanford University (Other)
Overall Status
Recruiting
CT.gov ID
NCT00398177
Collaborator
The Leukemia and Lymphoma Society (Other), Biospect Inc (Industry)
9,999
Enrollment
1
Location
1200
Duration (Months)
8.3
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The purpose of this study is to characterize the molecular and cell biology of the tumor cells in lymphoma.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    This research involves the study of lymphoma cells in order to better understand how the disease grows and spreads. This study may lead to the development of special materials that could be used, in the future, to treat lymphoma or to follow the response of lymphoma to treatment.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    9999 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease
    Study Start Date :
    Jan 1, 1999
    Anticipated Primary Completion Date :
    Jan 1, 2099
    Anticipated Study Completion Date :
    Jan 1, 2099

    Outcome Measures

    Primary Outcome Measures

    1. Collection of tumor tissue to characterize the molecular and cell biology of tumor cells in lymphoma. [The study will continue indefinitely.]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • Diagnosis of Hodgkin's disease or non-Hodgkin's lymphoma, any cellular classification, any stage, any grade.

    • Adult or pediatric patients receiving lymph node excision for purposes other than cancer therapy (i.e. tonsillectomy, sleep apnea).

    • A routine procedure for tissue collection is planned.

    • Ability to understand and the willingness to sign a written informed consent.

    Exclusion Criteria:
    • Patients without NHL or Hodgkin's disease

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Stanford University School of Medicine Stanford California United States 94305

    Sponsors and Collaborators

    • Stanford University
    • The Leukemia and Lymphoma Society
    • Biospect Inc

    Investigators

    • Principal Investigator: Ronald Levy, MD, Stanford University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Stanford University
    ClinicalTrials.gov Identifier:
    NCT00398177
    Other Study ID Numbers:
    • LYM0001
    • 76973
    • LYM0001
    • IRB-13500
    First Posted:
    Nov 10, 2006
    Last Update Posted:
    Aug 4, 2021
    Last Verified:
    Aug 1, 2021
    Additional relevant MeSH terms:
    Lymphoma
    Lymphoma, Non-Hodgkin
    Hodgkin Disease

    Study Results

    No Results Posted as of Aug 4, 2021